• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

英国初级保健中的慢性阻塞性肺疾病:发病率和危险因素。

Chronic obstructive pulmonary disease in UK primary care: incidence and risk factors.

机构信息

Spanish Centre for Pharmacoepidemiological Research (CEIFE), Madrid, 28004, Spain.

出版信息

COPD. 2009 Oct;6(5):369-79. doi: 10.1080/15412550903156325.

DOI:10.1080/15412550903156325
PMID:19863366
Abstract

We evaluated the association of chronic obstructive pulmonary disease (COPD) with modifiable risk factors such as smoking and prescription medications, and investigated possible risk factors unique to patients who had never smoked. The UK General Practice Research Database was used to identify a cohort of patients with a first diagnosis of COPD (n = 1927) along with age- and sex-matched controls without COPD (n = 16 546). The incidence of COPD diagnoses and the risks associated with medication use, co-morbidities, and demographic factors, were estimated. The incidence of COPD was 2.6 per 1000 person-years (95% confidence interval [CI]: 2.5-2.7) among 40-89 year-olds. The risk significantly increased in current and former smokers (OR: 6.15 [95% CI: 5.41-7.00] and 3.45 [95% CI: 2.96-4.02]), respectively. The risk was significantly lower in former smokers than current smokers (OR: 0.61; 95% CI: 0.52-0.71). Current statin use was significantly associated with a reduced risk (OR: 0.45; 95% CI: 0.25-0.80). In never smokers, risk factors included advanced age and obesity. The risk in never smokers was more strongly related to paracetamol use (OR: 1.82; 95% CI: 1.33-2.49) than in current and former smokers (OR: 1.48; 95% CI: 1.18-1.86). In summary, COPD is associated with a range of cardiovascular and respiratory conditions and the risk is influenced by current and past medications. While the risk factors are similar in smokers and never smokers, some were unique to never smokers. Moreover, subjects who stopped smoking had a substantially lower COPD risk than those who continued smoking.

摘要

我们评估了慢性阻塞性肺疾病(COPD)与可改变的风险因素(如吸烟和处方药物)的关联,并研究了从未吸烟的患者特有的潜在风险因素。使用英国普通实践研究数据库确定了一组首次诊断为 COPD 的患者(n = 1927)以及年龄和性别匹配的无 COPD 对照组(n = 16546)。估计了 COPD 诊断的发生率以及与药物使用、合并症和人口统计学因素相关的风险。40-89 岁患者 COPD 的发病率为 2.6/1000 人年(95%置信区间[CI]:2.5-2.7)。目前和曾经吸烟者的风险显著增加(比值比[OR]:6.15 [95%CI:5.41-7.00]和 3.45 [95%CI:2.96-4.02])。与当前吸烟者相比,前吸烟者的风险显著降低(OR:0.61;95%CI:0.52-0.71)。目前使用他汀类药物与降低风险显著相关(OR:0.45;95%CI:0.25-0.80)。在从不吸烟者中,风险因素包括年龄较大和肥胖。从不吸烟者的风险与对乙酰氨基酚的使用(OR:1.82;95%CI:1.33-2.49)比与当前和曾经吸烟者的使用(OR:1.48;95%CI:1.18-1.86)更密切相关。总之,COPD 与一系列心血管和呼吸系统疾病相关,且风险受当前和过去用药的影响。虽然吸烟者和从不吸烟者的风险因素相似,但有些因素是从不吸烟者特有的。此外,停止吸烟的受试者的 COPD 风险明显低于继续吸烟的受试者。

相似文献

1
Chronic obstructive pulmonary disease in UK primary care: incidence and risk factors.英国初级保健中的慢性阻塞性肺疾病:发病率和危险因素。
COPD. 2009 Oct;6(5):369-79. doi: 10.1080/15412550903156325.
2
Risk of fall in patients with COPD.COPD 患者的跌倒风险。
Thorax. 2018 Nov;73(11):1079-1080. doi: 10.1136/thoraxjnl-2017-211008. Epub 2018 Mar 21.
3
Characteristics and outcomes of chronic obstructive pulmonary disease in never smokers in Denmark: a prospective population study.丹麦从不吸烟人群中慢性阻塞性肺疾病的特征和结局:一项前瞻性人群研究。
Lancet Respir Med. 2013 Sep;1(7):543-50. doi: 10.1016/S2213-2600(13)70137-1. Epub 2013 Jul 29.
4
Risk factors for chronic obstructive pulmonary disease among never-smokers in Korea.韩国不吸烟者中慢性阻塞性肺疾病的危险因素。
Int J Chron Obstruct Pulmon Dis. 2015 Mar 5;10:497-506. doi: 10.2147/COPD.S77662. eCollection 2015.
5
Relationship between gastroesophageal reflux disease and COPD in UK primary care.英国初级医疗中胃食管反流病与慢性阻塞性肺疾病的关系
Chest. 2008 Dec;134(6):1223-1230. doi: 10.1378/chest.08-0902. Epub 2008 Aug 8.
6
Chronic obstructive pulmonary disease and lung cancer incidence in never smokers: a cohort study.慢性阻塞性肺疾病和肺癌在从不吸烟者中的发病率:一项队列研究。
Thorax. 2020 Jun;75(6):506-509. doi: 10.1136/thoraxjnl-2019-213732. Epub 2020 Apr 2.
7
Risk of chronic obstructive pulmonary disease in healthy individuals with high C-reactive protein levels by smoking status: a population-based cohort study in Korea.吸烟状况与高 C-反应蛋白水平的健康个体患慢性阻塞性肺疾病的风险:一项韩国基于人群的队列研究。
Int J Chron Obstruct Pulmon Dis. 2019 Sep 3;14:2037-2046. doi: 10.2147/COPD.S213665. eCollection 2019.
8
Risk of community-acquired pneumonia in chronic obstructive pulmonary disease stratified by smoking status: a population-based cohort study in the United Kingdom.按吸烟状况分层的慢性阻塞性肺疾病患者社区获得性肺炎风险:英国一项基于人群的队列研究
Int J Chron Obstruct Pulmon Dis. 2017 Aug 14;12:2425-2432. doi: 10.2147/COPD.S138435. eCollection 2017.
9
Epidemiology, severity, and treatment of chronic obstructive pulmonary disease in the United Kingdom by GOLD 2013.英国慢性阻塞性肺疾病的流行病学、严重程度及治疗(依据2013年慢性阻塞性肺疾病全球倡议)
Int J Chron Obstruct Pulmon Dis. 2015 May 13;10:925-37. doi: 10.2147/COPD.S82064. eCollection 2015.
10
Chronic Obstructive Pulmonary Disease and Smoking Status - United States, 2017.慢性阻塞性肺疾病与吸烟状况-美国,2017 年。
MMWR Morb Mortal Wkly Rep. 2019 Jun 21;68(24):533-538. doi: 10.15585/mmwr.mm6824a1.

引用本文的文献

1
Chronic Obstructive Pulmonary Disease Adverse Event Signals Associated with Potential Inhibitors of Glutathione Peroxidase 1: A Sequence Symmetry Analysis.慢性阻塞性肺疾病不良事件信号与潜在的谷胱甘肽过氧化物酶 1 抑制剂相关:序列对称分析。
Drug Saf. 2024 Jan;47(1):59-70. doi: 10.1007/s40264-023-01374-5. Epub 2023 Nov 23.
2
The role of polymorphisms on COPD susceptibility in southern Chinese.中国南方人群中基因多态性对慢性阻塞性肺疾病易感性的作用。
Heliyon. 2023 Sep 23;9(10):e20226. doi: 10.1016/j.heliyon.2023.e20226. eCollection 2023 Oct.
3
Motivational support intervention to reduce smoking and increase physical activity in smokers not ready to quit: the TARS RCT.
动机支持干预减少吸烟者的吸烟量并增加其运动量,适用于那些尚未准备好戒烟的吸烟者:TARS RCT 研究。
Health Technol Assess. 2023 Mar;27(4):1-277. doi: 10.3310/KLTG1447.
4
Sex-specific non-linear associations between body mass index and impaired pulmonary ventilation function in a community-based population: Longgang COPD study.基于社区人群的体重指数与肺通气功能受损之间的性别特异性非线性关联:龙岗慢性阻塞性肺疾病研究
Front Pharmacol. 2023 Mar 9;14:1103573. doi: 10.3389/fphar.2023.1103573. eCollection 2023.
5
Racing against time: leveraging preclinical models to understand pulmonary susceptibility to perinatal acetaminophen exposures.争分夺秒:利用临床前模型了解围产期对乙酰氨基酚暴露导致的肺部易感性。
Am J Physiol Lung Cell Mol Physiol. 2022 Jul 1;323(1):L1-L13. doi: 10.1152/ajplung.00080.2022. Epub 2022 May 3.
6
The association between exacerbation of chronic obstructive pulmonary disease and timing of paracetamol use: a cohort study in elderly Australians.慢性阻塞性肺疾病加重与扑热息痛使用时间的关联:澳大利亚老年人队列研究。
Respir Res. 2022 Apr 5;23(1):80. doi: 10.1186/s12931-022-02010-z.
7
Prediction of COPD risk accounting for time-varying smoking exposures.考虑吸烟暴露随时间变化的 COPD 风险预测。
PLoS One. 2021 Mar 10;16(3):e0248535. doi: 10.1371/journal.pone.0248535. eCollection 2021.
8
Acetaminophen and the Developing Lung: Could There Be Lifelong Consequences?对乙酰氨基酚与发育中的肺:会有终身影响吗?
J Pediatr. 2021 Aug;235:264-276.e1. doi: 10.1016/j.jpeds.2021.02.026. Epub 2021 Feb 20.
9
Emerging Treatments for COPD: Evidence to Date on Revefenacin.COPD 的新兴治疗方法:瑞氟米特的现有证据。
COPD. 2020 Feb;17(1):112-119. doi: 10.1080/15412555.2019.1702010. Epub 2019 Dec 13.
10
Factors affecting the development of airflow limitation among South Korean smokers.影响韩国吸烟者气流受限发展的因素。
Tob Induc Dis. 2019 Mar 1;17:16. doi: 10.18332/tid/103088. eCollection 2019.